EIGHTH AMENDMENT TO LEASETo Lease • February 23rd, 2016 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Massachusetts
Contract Type FiledFebruary 23rd, 2016 Company Industry JurisdictionThis EIGHTH AMENDMENT TO LEASE (this “Amendment”) is made as of the 1st day of November, 2015, (the “Effective Date”) by and between UNIVERSITY OF MASSACHUSETTS DARTMOUTH, an institution of Higher Education of the Commonwealth of Massachusetts, with an address of 285 Old Westport Rd. North Dartmouth Massachusetts 02747 (“Landlord”) and CELLDEX THERAPEUTICS, INC. (formerly AVANT Immunotherapeutics, Inc.), a Delaware corporation, with an address of 119 Fourth Avenue, Needham, Massachusetts (“Tenant”).
SECOND AMENDMENT TO LEASETo Lease • February 23rd, 2016 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Massachusetts
Contract Type FiledFebruary 23rd, 2016 Company Industry JurisdictionThis Second Amendment to Lease (this “Amendment”) is dated as of August 1, 2015, by and between DIV NEEDHAM 115 LLC, a Massachusetts limited liability company (successor-in-interest to Fourth Avenue Ventures Limited Partnership), as landlord (“Landlord”), and CELLDEX THERAPEUTICS, INC., a Delaware corporation (successor-by name-change to T Cell Sciences, Inc. and Avant Immunotherapeutics, Inc.), as tenant (“Tenant”), with respect to that certain Lease dated as of May 1, 1996 (the “1996 Lease”), as amended by that certain First Amendment to Lease dated as of November 29, 2005 (the “First Amendment”; the 1996 Lease as amended by the First Amendment is referred to herein as the “Original Lease”, and the Original Lease as amended hereby is referred to herein as the “Lease”), by and between Landlord and Tenant, regarding certain premises (the “Existing Premises”) constituting approximately 35,189 rentable square feet on the first (1st) floor of the building located at 115-119 Fourth Avenue,